MAPT and Alzheimer disease: The study was principally motivated by previous findings showing that NEVs and AEVs from AD patients compared to controls carry high levels of proteins associated with AD pathogenesis, such as tTau, p181-Tau and Aβ42 in NEVs [9,10,12,16,17,19], and complement C1q in AEVs [15].